A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home 2012 February
formats

News from Stanford: Modelling Tissue as a Dielectric Shows Feasibility of Inductive Power Transfer at 1 GHz

Stanford Engineering assistant professor  Ada Poon demonstrated a tiny, wirelessly powered, self-propelled medical device capable of controlled motion through blood.  The device drives electrical current directly through the fluid, which in the presence of an external magnetic field creates a directional force that pushes the device forward. This type of device is capable of moving at

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on News from Stanford: Modelling Tissue as a Dielectric Shows Feasibility of Inductive Power Transfer at 1 GHz  comments 
formats

Medtronic’s Q3 AIMD Earnings: CRM 3% Down, Neuromodulation 4% Up

Today Medtronic announced financial results for its third quarter of fiscal year 2012, which ended January 27, 2012. According to the report: “CRDM third quarter revenue of $1.192 billion decreased 2 percent as reported or 3% on a constant currency basis. Third quarter revenue from ICDs was $674 million,  down 9 percent on a constant

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic’s Q3 AIMD Earnings: CRM 3% Down, Neuromodulation 4% Up  comments 
formats

MicroCHIPS Announces Clinical Results for First Successful Human Trial of Programmable Microchip-Based Drug Delivery Device

Last month I posted some background on MicroCHIPS, the MIT spinoff to develop implantable sensors and drug-delivery devices.  I concluded that post with the February 2011 announcement that MicroCHIPS started its clinical trial to assess the pharmacokinetics of long-term parathyroid hormone (hPTH 1-34) delivery in women with osteoporosis. MicroCHIPS announced today the results of the first successful human

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on MicroCHIPS Announces Clinical Results for First Successful Human Trial of Programmable Microchip-Based Drug Delivery Device  comments 
formats

iPacemaker Implantable Pacemaker/ICD Database for the iPhone

My friend and colleague Dr. Irit Yaniv alerted me to this iPhone app that was just released.  It is an implantable pacemaker and defibrillator database that, according to its author, displays up to 70 parameters for each model, includes battery and longevity data, and links directly to product manuals.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on iPacemaker Implantable Pacemaker/ICD Database for the iPhone  comments 
formats

The Australian Pacemaker: Telectronics (1965-1995)

In 1965, Australian medical device pioneer Noel Gray established Telectronics – Australia’s first manufacturing facility for producing pacemakers that were designed in-house.  Telectronics was an innovative developer, achieving some major successes in the early cardiac pacing field, for example, Telectronics’ leads allowed narrowing the pacing pulse to its current nominal of 0.5 milliseconds; encapsulating the pacemaker in titanium

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
3 Comments  comments 
formats

Micro Systems Technologies Offers Active Implantable Medical Device Development/Manufacturing Services

Micro Systems Technologies (MST) is the vertically-integrated supplier of microelectronics and implantable-grade components to Biotronik.  It now offers its development and manufacturing services to others. Through its companies, MST offers high-reliability microelectronic modules for implantable medical devices such as pacemakers, defibrillators, neurostimulators, and cochlear implants. MST can provide integrated solutions encompassing everything from conceptual design through high-volume

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Micro Systems Technologies Offers Active Implantable Medical Device Development/Manufacturing Services  comments 
formats

VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology

  On January 17, 2012, VeriTeQ Acquisition Corporation of Delray Beach, FL announced that it acquired the VeriChip implantable RFID technology and its related Health Link personal health record from PositiveID Corporation.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on VeriTeQ Acquisition Corporation Acquires Implantable, FDA-Cleared VeriChip Technology  comments 
formats

DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US

The DF-4 Connector was recently introduced by a joint group of CRM companies, physicians, and regulatory agencies as a way of easing the implant of ICDs by reducing defibrillation connections from three to one and by minimizing the number of set screws.  Prior to the development of the DF-4, traditional high-voltage connector systems required up to three connections.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on DF-4 Connectors for Implantable Cardioverter Defibrillators Enter Use in the US  comments 
formats

Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%

Today Boston Scientific Corporation announced financial results for the fourth quarter and full year ended December 31, 2011.  Summarizing the AIMD data: On a constant-currency basis, Q4 2011 CRM sales were $482M compared to $564M in Q4 2010, or  down 15% On a constant-currency basis, 2011 CRM sales were $2,087M compared to $2,180M in Q4 2010,

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific’s Active Implantable Sales for 2011: CRM Down 7%, Neuromodulation Up 10%  comments